These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7652970)
1. [Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study]. Russell MB; Holm-Thomsen OE; Nielsen MR; Cleal A; Pilgrim AJ; Olesen J Ugeskr Laeger; 1995 Apr; 157(16):2320-3. PubMed ID: 7652970 [TBL] [Abstract][Full Text] [Related]
2. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice. Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
4. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
6. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
7. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Diener HC Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults. Winner P; Adelman J; Aurora S; Lener ME; Ames M Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114 [TBL] [Abstract][Full Text] [Related]
12. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P; Landy S; Richardson M; Ames M Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449 [TBL] [Abstract][Full Text] [Related]
14. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Sargent J; Kirchner JR; Davis R; Kirkhart B Neurology; 1995 Aug; 45(8 Suppl 7):S10-4. PubMed ID: 7644079 [TBL] [Abstract][Full Text] [Related]
15. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Diener HC; Gendolla A; Gebert I; Beneke M Headache; 2005; 45(7):874-82. PubMed ID: 15985104 [TBL] [Abstract][Full Text] [Related]
16. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group. Tepper SJ; Cochran A; Hobbs S; Woessner M Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565 [TBL] [Abstract][Full Text] [Related]
17. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. Silberstein SD; Mannix LK; Goldstein J; Couch JR; Byrd SC; Ames MH; McDonald SA; Lener SE; Toso C Neurology; 2008 Jul; 71(2):114-21. PubMed ID: 18606965 [TBL] [Abstract][Full Text] [Related]
18. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Cutler N; Mushet GR; Davis R; Clements B; Whitcher L Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082 [TBL] [Abstract][Full Text] [Related]
19. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial. Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results]. Centonze V; Polito MB; Di Bari M; Fabbri L; Cassiano MA; Bassi A; Albano O Clin Ter; 1995 Nov; 146(11):721-8. PubMed ID: 8720348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]